Top compounds associated with response to ADGRL2


Feature Type Standardized
Nominal ANOVA
mRNA Bosutinib FIMM pan-cancer AAC -0.58 0.03
mRNA ABT-263 FIMM pan-cancer AAC -0.55 0.0002
mRNA AMG-706 FIMM pan-cancer AAC -0.35 0.05
mRNA BIRB 0796 FIMM pan-cancer AAC -0.34 0.09
mRNA serdemetan FIMM pan-cancer AAC -0.31 0.07
mRNA PD-0332991 FIMM pan-cancer AAC -0.3 0.1
mRNA lenalidomide FIMM pan-cancer AAC -0.28 0.1
mRNA Nilotinib FIMM pan-cancer AAC -0.27 0.2
mRNA Axitinib FIMM pan-cancer AAC -0.25 0.1
mRNA Tipifarnib FIMM pan-cancer AAC -0.24 0.09
Download CSV